Neuro-Behçet syndrome

作者: Sabahattin Saip , Gulsen Akman-Demir , Aksel Siva

DOI: 10.1016/B978-0-7020-4088-7.00110-3

关键词:

摘要: Behcet syndrome (BS) is an idiopathic chronic relapsing multisystem vascular-inflammatory disease of unknown origin. As the affects many organs and systems shows a wide range clinical manifestations presentations, it prefereable to call Behcet's rather than disease. Nervous system involvement, known as "neuro-BS" (NBS), seen in about 5-10% all cases. Clinical imaging evidence suggests that primary neurologic involvement BS may be subclassified into two major forms: first, which majority patients, characterized central nervous with focal or multifocal parenchymal mostly presenting subacute brainstem hemiparesis (intra-axial NBS); other, has few symptoms better prognosis, caused by isolated cerebral venous sinus thrombosis intracranial hypertension (extra-axial NBS), occurring 10-20% These types are rarely same individual, their pathogenesis likely different. Isolated behavioral syndromes peripheral rare, whereas vascular type headache relatively common independent from involvement. Neurologic complications secondary systemic BS, well related treatments considered syndrome. The core histopathologic phenomenon seems vasculitic some cases, low-grade nonspecific inflammation others. this so heterogeneous, difficult predict its course response treatment. Currently, treatment options for NBS limited attack therapies high-dose intravenous methylprednisolone followed prolonged oral taper, symptomatic management, generally use azathioprine, cyclophosphamide, interferon-α anti-TNF agents long-term preventive treatment, although there no efficacy.

参考文章(131)
I Tugal-Tutkun, M Kurtuncu, G Akman-Demir, O Ayranci, M Mutlu, E N Vanli, Cyclosporine for Behçet's uveitis: is it associated with an increased risk of neurological involvement? Clinical and Experimental Rheumatology. ,vol. 26, ,(2008)
T Kansu, E Kansu, T Zileli, P Kirkali, Optic neuropathy in Behçet's disease. Journal of clinical neuro-ophthalmology. ,vol. 9, pp. 277- 280 ,(1989)
Cuyan Demirkesen, Büge Öz, Süha Göksel, Behçet’s Disease: Pathology Behçet’s Syndrome. pp. 215- 241 ,(2010) , 10.1007/978-1-4419-5641-5_13
H R Lippman, F Aydin, M G Hadfield, K M Sanders, Neuro-Behçet's disease. Clinical Neuropathology. ,vol. 16, pp. 55- 60 ,(1996)
D. Bogdanova, I. Milanov, D. Georgiev, Parkinsonian syndrome as a neurological manifestation of Behçet's disease. Canadian Journal of Neurological Sciences. ,vol. 25, pp. 82- 85 ,(1998) , 10.1017/S0317167100033552
Raquel C. Gardner, Jeremy D. Schmahmann, Ataxia and cerebellar atrophy--a novel manifestation of neuro-Behçet disease? Movement Disorders. ,vol. 23, pp. 307- 308 ,(2008) , 10.1002/MDS.21834
Sabahattin Saip, Aksel Siva, Ayse Altintas, Asli Kiyat, Emire Seyahi, Vedat Hamuryudan, Hasan Yazici, Headache in Behçet's syndrome. Headache. ,vol. 45, pp. 911- 919 ,(2005) , 10.1111/J.1526-4610.2005.05160.X
A Gül, FA Uyar, Murat Inanç, L Ocal, JH Barrett, O Aral, M Koniçe, G Saruhan-Direskeneli, A weak association of HLA-B*2702 with Behçet’s disease Genes and Immunity. ,vol. 3, pp. 368- 372 ,(2002) , 10.1038/SJ.GENE.6363863
Osman Kizilkilic, Sait Albayram, Ibrahim Adaletli, Halil Ak, Civan Islak, Naci Kocer, Endovascular treatment of Behçet's disease-associated intracranial aneurysms: report of two cases and review of the literature. Neuroradiology. ,vol. 45, pp. 328- 334 ,(2003) , 10.1007/S00234-003-0952-X
N. Mizuki, M. Ota, M. Kimura, S. Ohno, H. Ando, Y. Katsuyama, M. Yamazaki, K. Watanabe, K. Goto, S. Nakamura, S. Bahram, H. Inoko, Triplet repeat polymorphism in the transmembrane region of the MICA gene: A strong association of six GCT repetitions with Behçet disease Proceedings of the National Academy of Sciences of the United States of America. ,vol. 94, pp. 1298- 1303 ,(1997) , 10.1073/PNAS.94.4.1298